EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Understanding the influence of transfusion and blood loss on tranexamic acid concentration in scoliosis surgery with blood loss

Paula Alexandra Sá iD, Luisa Barreiros iD, Marcela A Segundo iD, Eugénia Cruz iD, Sibylle Langenecker iD

British Journal of Clinical Pharmacology · 2025

DOI: 10.1002/bcp.70402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Paula Alexandra Sá und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Intensive Care and Emergency, Centro Hospitalar Universitário de Santo António, Unidade Local de Saúde de Santo Antóni…. Hauptthemen laut MEDLINE: Tranexamic Acid, Scoliosis, Blood Loss, Surgical, Antifibrinolytic Agents. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: FCT/MECI, Fundação para a Ciência e a Tecnologia and Ministério da Educação, Ciência e Inovação, Fundo para a Investigação e Desenvolvimento do Centro Hospitalar Universitário do Porto, Fundação para a Ciência e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Tranexamic acid (TXA) stabilizes clot formation by inhibiting fibrin degradation and improves postoperative outcomes. However, rare adverse events (e.g., thrombosis, seizures) warrant dose–risk evaluation. This study examines how perioperative blood loss and transfusion practices affect TXA concentrations during paediatric scoliosis surgery.

Methods

Forty‐three patients undergoing scoliosis surgery with TXA were retrospectively analysed. The study assessed the impact of packed red blood cell (PRBC) transfusion on plasma TXA levels and whether maintaining concentrations ≥10 μg/mL correlated with intraoperative blood loss. TXA levels were measured using UHPLC–MS/MS.

Results

Median TXA concentration 30 min after the loading dose was 37.8 μg/mL (IQR: 31.4–39.6 μg/mL), decreasing to 10.6 μg/mL (IQR: 9.7–13.5 μg/mL) after transfusion. At surgery end, the mean concentration was 12.9 ± 2.5 μg/mL. Thirty‐one patients maintained TXA levels ≥10 μg/mL, associated with ~80% inhibition of tissue plasminogen activator . Of six patients below this threshold, five had received transfusions. A significant correlation was found between higher intraoperative blood loss and lower TXA levels, consistent with a dilutional effect. In contrast, among patients with TXA ≥ 10 μg/mL, correlation with blood loss was weak (Spearman's ρ = −0.11, p = 0.54). Findings suggest homologous PRBC transfusion reduces plasma TXA through volume expansion.

Conclusions

Sustaining TXA concentrations >10 μg/mL is essential for antifibrinolytic efficacy and haemostatic outcomes. The dilutional impact of PRBC transfusion underscores the need for intraoperative dose adjustment. Optimizing TXA dosing requires understanding pharmacokinetics and patient variability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidScoliosisBlood Loss, SurgicalAntifibrinolytic AgentsErythrocyte TransfusionHumansFemaleMaleChildRetrospective StudiesAdolescent

Stichwörter der Autor:innen

blood lossblood transfusionclinical pharmacologyscoliosis surgerytranexamic acid

Substanzen

Tranexamic AcidAntifibrinolytic Agents

Autor:innen und Institutionen

  • Department of Anaesthesiology, Intensive Care and Emergency, Centro Hospitalar Universitário de Santo António, Unidade Local de Saúde de Santo António, Largo Professor Abel Salazar, 4099-001, Porto, Portugal.
  • LAQV, REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313, Porto, Portugal.
  • Escola Superior de Saúde, Instituto Politécnico do Porto, Rua Dr. António Bernardino de Almeida 400, 4200-072, Porto, Portugal.
  • Department Imuno-Haemotherapy, Centro Hospitalar Universitário de Santo António, Unidade Local de Saúde de Santo António, Largo Professor Abel Salazar, 4099-001, Porto, Portugal.
  • Instituto Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313, Porto, Portugal.
  • Department of Anesthesia and Intensive Care, Evangelical Hospital Vienna and Sigmund Freud Private University, Hans-Sachs-Gasse, 10-12 1180, Vienna, Austria.

ORCID-Profile: Paula Alexandra Sá, Luisa Barreiros, Marcela A Segundo, Eugénia Cruz, Sibylle Langenecker

Förderung

  • FCT/MECI, Fundação para a Ciência e a Tecnologia and Ministério da Educação, Ciência e Inovação
  • Fundo para a Investigação e Desenvolvimento do Centro Hospitalar Universitário do Porto
  • Fundação para a Ciência e a Tecnologia

Zitieren

APA

Sá, P. A., Barreiros, L., Segundo, M. A., Cruz, E., & Langenecker, S. (2025). Understanding the influence of transfusion and blood loss on tranexamic acid concentration in scoliosis surgery with blood loss. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70402

Vancouver

Sá PA, Barreiros L, Segundo MA, Cruz E, Langenecker S. Understanding the influence of transfusion and blood loss on tranexamic acid concentration in scoliosis surgery with blood loss. British Journal of Clinical Pharmacology. 2025. doi:10.1002/bcp.70402

BibTeX
@article{S2025,
  author = {Sá, Paula Alexandra and Barreiros, Luisa and Segundo, Marcela A and Cruz, Eugénia and Langenecker, Sibylle},
  title = {Understanding the influence of transfusion and blood loss on tranexamic acid concentration in scoliosis surgery with blood loss},
  journal = {British Journal of Clinical Pharmacology},
  year = {2025},
  doi = {10.1002/bcp.70402}
}
Kostenlos starten →